Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses

Abstract

Hyaline molds, widely distributed in nature, are an important and increasing cause of invasive fungal infections in humans, likely due to an expanding population of immunosuppressed hosts, increases in antifungal resistance, and improvements in laboratory diagnostics. Sinopulmonary disease and disseminated infection are common manifestations in neutropenic patients and transplant recipients, whereas, catheter-related and localized soft tissue infections predominate in immunocompetent hosts. These organisms are not reliably differentiated based on their morphology in tissue; rather, efforts should be made to establish a microbiologic diagnosis via culture or molecular-based methods to guide antifungal management and inform prognosis. Herein, we review the epidemiology, clinical manifestations, diagnosis, and management of these opportunistic pathogens known to cause hyalohyphomycoses: Scedosporium spp., Lomentospora prolificans, Fusarium spp., Scopulariopsis spp., Arthrographis kalrae, Trichoderma spp., Acremonium spp., Paecilomyces variotii, Purpureocillium lilacinum, and Penicillium species.

Keywords

Fusarium - Scedosporium - Scopulariopsis - Trichoderma - Acremonium - Arthrographis - Paecilomyces - Penicillium - hyalohyphomycoses

• References

• 1 Ramirez-Garcia A, Pellon A, Rementeria A. , et al. Scedosporium and Lomentospora: an updated overview of underrated opportunists. Med Mycol 2018; 56 (Suppl. 01) 102-125
• 2 Cortez KJ, Roilides E, Quiroz-Telles F. , et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21 (01) 157-197
• 3 Seidel D, Meißner A, Lackner M. , et al. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope^® . Crit Rev Microbiol 2019; 45 (01) 1-21
• 4 Guerrero A, Torres P, Duran MT, Ruiz-Díez B, Rosales M, Rodriguez-Tudela JL. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet 2001; 357 (9264): 1267-1268
• 5 Alvarez M, Lopez Ponga B, Rayon C. , et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33 (12) 3290-3295
• 6 Park BJ, Pappas PG, Wannemuehler KA. , et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011; 17 (10) 1855-1864
• 7 Cobo F, Lara-Oya A, Rodríguez-Granger J, Sampedro A, Aliaga-Martínez L, Navarro-Marí JM. Infections caused by Scedosporium/Lomentospora species: clinical and microbiological findings in 21 cases. Med Mycol 2018; 56 (08) 917-925
• 8 Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. Host immune response against Scedosporium species. Med Mycol 2009; 47 (04) 433-440
• 9 Husain S, Muñoz P, Forrest G. , et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40 (01) 89-99
• 10 Safdar A, Papadopoulos EB, Young JW. Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 2002; 4 (04) 212-217
• 11 Tong SYC, Peleg AY, Yoong J, Handke R, Szer J, Slavin M. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transpl Infect Dis 2007; 9 (03) 241-243
• 12 Penteado FD, Litvinov N, Sztajnbok J. , et al. Lomentospora prolificans fungemia in hematopoietic stem cell transplant patients: first report in South America and literature review. Transpl Infect Dis 2018; 20 (04) e12908
• 13 Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis 2006; 43 (12) 1580-1584
• 14 Lionakis MS, Lewis RE, Kontoyiannis DP. Breakthrough invasive mold infections in the hematology patient: current concepts and future directions. Clin Infect Dis 2018; 67 (10) 1621-1630
• 15 Neofytos D, Fishman JA, Horn D. , et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12 (03) 220-229
• 16 Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis 2014; 16 (04) 578-587
• 17 Cimon B, Carrère J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19 (01) 53-56
• 18 Blyth CC, Middleton PG, Harun A, Sorrell TC, Meyer W, Chen SCA. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?. Med Mycol 2010; 48 (Suppl. 01) S37-S44
• 19 McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold infections of the central nervous system. N Engl J Med 2014; 371 (02) 150-160
• 20 Tortorano AM, Richardson M, Roilides E. , et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 2014; 20 (Suppl. 03) 27-46
• 21 Rahman FU, Irfan M, Fasih N, Jabeen K, Sharif H. Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature. Infection 2016; 44 (01) 127-132
• 22 Borghi E, Iatta R, Manca A, Montagna MT, Morace G. Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis. Med Mycol 2010; 48 (Suppl. 01) S108-S113
• 23 Sheu R, Bricker AO, Sahi H, Mohammed TLH. Pseudallescheria boydii (Scedosporium species) in 3 lung transplant recipients: computed tomography findings and literature review. J Comput Assist Tomogr 2009; 33 (02) 247-252
• 24 Pellón Dabén R, Marco de Lucas E, Martín Cuesta L. , et al. Imaging findings of pulmonary infection caused by Scedosporium prolificans in a deep immunocompromised patient. Emerg Radiol 2008; 15 (01) 47-49
• 25 Kim SH, Ha YE, Youn JC. , et al. Fatal scedosporiosis in multiple solid organ allografts transmitted from a nearly-drowned donor. Am J Transplant 2015; 15 (03) 833-840
• 26 Leek R, Aldag E, Nadeem I. , et al. Scedosporiosis in a combined kidney and liver transplant recipient: a case report of possible transmission from a near-drowning donor. Case Rep Transplant 2016; 2016: 1879529
• 27 Parize P, Boussaud V, Poinsignon V. , et al. Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: a single-center 15-year experience. Transpl Infect Dis 2017; 19 (05) 1-8
• 28 Walsh T, Hayden R, Larone D. Larone's medically Important Fungi: A Guide to Identification. 6th ed. Washington, DC: ASM Press; 2018
• 29 Walsh TJ, McCarthy MW. The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases. Expert Rev Mol Diagn 2019; 19 (03) 241-248
• 30 Harun A, Blyth CC, Gilgado F, Middleton P, Chen SCA, Meyer W. Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol 2011; 49 (04) 1508-1512
• 31 McCarthy MW, Katragkou A, Iosifidis E, Roilides E, Walsh TJ. Recent advances in the treatment of scedosporiosis and fusariosis. J Fungi (Basel) 2018; 4 (02) 73
• 32 Tamaki M, Nozaki K, Onishi M, Yamamoto K, Ujiie H, Sugahara H. Fungal meningitis caused by Lomentospora prolificans after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2016; 18 (04) 601-605
• 33 Lackner M, de Hoog GS, Verweij PE. , et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother 2012; 56 (05) 2635-2642
• 34 Troke P, Aguirrebengoa K, Arteaga C. , et al; Global Scedosporium Study Group. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 2008; 52 (05) 1743-1750
• 35 Meletiadis J, Mouton JW, Meis JFGM, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003; 47 (01) 106-117
• 36 Biswas C, Sorrell TC, Djordjevic JT, Zuo X, Jolliffe KA, Chen SCA. In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. J Antimicrob Chemother 2013; 68 (12) 2842-2846
• 37 Kesson AM, Bellemore MC, O'Mara TJ, Ellis DH, Sorrell TC. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphosphocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis 2009; 48 (09) 1257-1261
• 38 Quaesaet L, Stindel E, Lanternier F. , et al. Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection. Med Mal Infect 2018; 48 (01) 63-65
• 39 O'Donnell K, Sutton DA, Rinaldi MG. , et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48 (10) 3708-3718
• 40 Tortorano AM, Prigitano A, Esposto MC. , et al; ECMM Working Group. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis 2014; 33 (09) 1623-1630
• 41 Al-Hatmi AM, Hagen F, Menken SB, Meis JF, de Hoog GS. Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015. Emerg Microbes Infect 2016; 5 (12) e124
• 42 Segal BH, Walsh TJ, Liu JM, Wilson JD, Kwon-Chung KJ. Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia. J Clin Microbiol 1998; 36 (06) 1772-1776
• 43 Palmore TN, Shea YR, Childs RW, Sherry RM, Walsh TJ. Fusarium proliferatum soft tissue infection at the site of a puncture by a plant: recovery, isolation, and direct molecular identification. J Clin Microbiol 2010; 48 (01) 338-342
• 44 Schell WA, Perfect JR. Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol 1996; 34 (05) 1333-1336
• 45 Anaissie EJ, Kuchar RT, Rex JH. , et al. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis 2001; 33 (11) 1871-1878
• 46 Raad I, Tarrand J, Hanna H. , et al. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol 2002; 23 (09) 532-537
• 47 Mehl HL, Epstein L. Sewage and community shower drains are environmental reservoirs of Fusarium solani species complex group 1, a human and plant pathogen. Environ Microbiol 2008; 10 (01) 219-227
• 48 Stergiopoulou T, Meletiadis J, Roilides E. , et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol 2007; 127 (03) 349-355
• 49 Kontoyiannis DP, Marr KA, Park BJ. , et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis 2010; 50 (08) 1091-1100
• 50 Pagano L, Caira M, Candoni A. , et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91 (08) 1068-1075
• 51 Nucci M, Marr KA, Queiroz-Telles F. , et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38 (09) 1237-1242
• 52 Nucci M, Garnica M, Gloria AB. , et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013; 19 (08) 745-751
• 53 Garnica M, da Cunha MO, Portugal R, Maiolino A, Colombo AL, Nucci M. Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients. Clin Infect Dis 2015; 60 (06) 875-880
• 54 Shoham S, Dominguez EA. ; AST Infectious Diseases Community of Practice. Emerging fungal infections in solid organ transplant recipients: Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33 (09) e13525
• 55 Nambiar P, Cober E, Johnson L, Brizendine KD. Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: case report and review of Fusarium infections in solid organ transplantation. Transpl Infect Dis 2018; 20 (03) e12872
• 56 Chang DC, Grant GB, Donnell KO. , et al. Multistate outbreak of Fusarium of a contact lens solution. JAMA 2006; 296 (08) 953-963
• 57 Khor WB, Aung T, Saw SM. , et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA 2006; 295 (24) 2867-2873
• 58 Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35 (08) 909-920
• 59 Warkentien T, Rodriguez C, Lloyd B. , et al; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group. Invasive mold infections following combat-related injuries. Clin Infect Dis 2012; 55 (11) 1441-1449
• 60 Georgiadou SP, Velegraki A, Arabatzis M. , et al. Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece. J Hosp Infect 2014; 86 (04) 267-271
• 61 Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20 (04) 695-704
• 62 Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect 2010; 60 (05) 331-337
• 63 Nucci M, Anaissie EJ, Queiroz-Telles F. , et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98 (02) 315-319
• 64 Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90 (03) 999-1008
• 65 Nucci F, Nouér SA, Capone D, Nucci M. Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis. Clin Microbiol Infect 2018; 24 (10) 1105.e1-1105.e4
• 66 Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med 2015; 36 (05) 706-714
• 67 Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol 2008; 190 (06) 1605-1609
• 68 Nucci M, Carlesse F, Cappellano P. , et al. Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing. PLoS One 2014; 9 (01) e87784
• 69 Tortorano AM, Esposto MC, Prigitano A. , et al. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol 2012; 50 (03) 1051-1053
• 70 Al-Hatmi AMS, Bonifaz A, Ranque S, Sybren de Hoog G, Verweij PE, Meis JF. Current antifungal treatment of fusariosis. Int J Antimicrob Agents 2018; 51 (03) 326-332
• 71 Espinel-Ingroff A, Colombo AL, Cordoba S. , et al. International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrob Agents Chemother 2015; 60 (02) 1079-1084
• 72 Cornely OA, Arikan-Akdagli S, Dannaoui E. , et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014; 20 (Suppl. 03) 5-26
• 73 Horn DL, Freifeld AG, Schuster MG, Azie NE, Franks B, Kauffman CA. Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry. Mycoses 2014; 57 (11) 652-658
• 74 Herbrecht R, Kessler R, Kravanja C, Meyer MH, Waller J, Letscher-Bru V. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J Heart Lung Transplant 2004; 23 (12) 1451-1454
• 75 Al-Hatmi AMS, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother 2015; 70 (04) 1068-1071
• 76 Cornely OA, Ostrosky-Zeichner L, Rahav G, Mahav R, Zeiher B, Lee M. Outcomes in patients with invasive mold disease caused by Fusarium or Scedosporium spp. treated with isavuconazole: experience from the VITAL and SECURE trials. Paper presented at: 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting. Washington, DC; 2014
• 77 Quillen K, Wong E, Scheinberg P. , et al. Granulocyte transfusions in severe aplastic anemia: an eleven-year experience. Haematologica 2009; 94 (12) 1661-1668
• 78 Dignani MC, Anaissie EJ, Hester JP. , et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997; 11 (10) 1621-1630
• 79 Dotis J, Simitsopoulou M, Dalakiouridou M. , et al. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus . J Antimicrob Chemother 2008; 61 (04) 810-817
• 80 Roilides E, Lyman CA, Armstrong D, Stergiopoulou T, Petraitiene R, Walsh TJ. Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani . Mycoses 2006; 49 (02) 109-113
• 81 Nucci M, Shoham S, Abdala E. , et al. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?. Mycoses 2019; 62 (05) 413-417
• 82 Paredes K, Capilla J, Mayayo E, Guarro J. Virulence and resistance to antifungal therapies of Scopulariopsis species. Antimicrob Agents Chemother 2016; 60 (04) 2063-2068
• 83 Sandoval-Denis M, Sutton DA, Fothergill AW. , et al. Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs. J Clin Microbiol 2013; 51 (12) 3937-3943
• 84 Pérez-Cantero A, Guarro J. Current knowledge on the etiology and epidemiology of Scopulariopsis infections. Med Mycol 2019; (e-pub ahead of print).
• 85 Neglia JP, Hurd DD, Ferrieri P, Snover DC. Invasive Scopulariopsis in the immunocompromised host. Am J Med 1987; 83 (06) 1163-1166
• 86 Huang L, Chen W, Guo L. , et al. Scopulariopsis/Microascus isolation in lung transplant recipients: a report of three cases and a review of the literature. Mycoses 2019; 62 (10) 883-892
• 87 Shaver CM, Castilho JL, Cohen DN. , et al. Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement. Am J Transplant 2014; 14 (12) 2893-2897
• 88 Rakita RM, Lease ED, Edelman JD, Mulligan MS. Successful treatment of Scopulariopsis infection in a lung transplant recipient. Am J Transplant 2015; 15 (07) 2010-2010
• 89 Iwen PC, Schutte SD, Florescu DF, Noel-Hurst RK, Sigler L. Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species. Med Mycol 2012; 50 (06) 561-569
• 90 Kurata K, Nishimura S, Ichikawa H. , et al. Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia. Int J Hematol 2018; 108 (06) 658-664
• 91 Salmon A, Debourgogne A, Vasbien M. , et al. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature. Clin Microbiol Infect 2010; 16 (05) 508-512
• 92 Pate MJ, Hemmige V, Woc-Colburn L, Restrepo A. Successful eradication of invasive Scopulariopsis brumptii in a liver transplant recipient. Transpl Infect Dis 2016; 18 (02) 275-279
• 93 Arroyo MA, Walls TB, Relich RF, Davis TE, Schmitt BH. The brief case: Scopulariopsis endocarditis—a case of mistaken Takayasu's arteritis. J Clin Microbiol 2017; 55 (09) 2567-2572
• 94 Cawcutt K, Baddour LM, Burgess M. A case of Scopulariopsis brevicaulis endocarditis with mycotic aneurysm in an immunocompetent host. Case Rep Med 2015; 2015: 872871
• 95 Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19 (03) 402-408
• 96 Vaidya PS, Levine JF. Scopulariopsis peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12 (01) 78-79
• 97 Vollmer T, Störmer M, Kleesiek K, Dreier J. Evaluation of novel broad-range real-time PCR assay for rapid detection of human pathogenic fungi in various clinical specimens. J Clin Microbiol 2008; 46 (06) 1919-1926
• 98 Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis . Antimicrob Agents Chemother 2006; 50 (06) 2248-2250
• 99 Corzo-León DE, Satlin MJ, Soave R. , et al. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses 2015; 58 (06) 325-336
• 100 Chin-Hong PV, Sutton DA, Roemer M, Jacobson MA, Aberg JA. Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS. J Clin Microbiol 2001; 39 (02) 804-807
• 101 Sugiura Y, Hironaga M. Arthrographis kalrae, a rare causal agent of onychomycosis, and its occurrence in natural and commercially available soils. Med Mycol 2010; 48 (02) 384-389
• 102 Vos CG, Murk JLAN, Hartemink KJ, Daniels JMA, Paul MA, Debets-Ossenkopp YJ. A rare pulmonary infection caused by Arthrographis kalrae . J Med Microbiol 2012; 61 (Pt 4): 593-595
• 103 Fiscarelli EV, Ricciotti G, Rossitto M, Pompilio A, Tuccio Guarna Assanti V, Lucidi V. A cystic fibrosis child with lung function decline. J Cyst Fibros 2019; 18 (06) e62-e64
• 104 Denis J, Sabou M, Degot T, Candolfi E, Letscher-Bru V. First case of Arthrographis kalrae fungemia in a patient with cystic fibrosis. Med Mycol Case Rep 2016; 14: 8-11
• 105 Sandoval-Denis M, Giraldo A, Sutton DA, Fothergill AW, Guarro J. In vitro antifungal susceptibility of clinical isolates of Arthrographis kalrae, a poorly known opportunistic fungus. Mycoses 2014; 57 (04) 247-248
• 106 Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (Suppl. 01) 48-66
• 107 Sandoval-Denis M, Sutton DA, Cano-Lira JF. , et al. Phylogeny of the clinically relevant species of the emerging fungus Trichoderma and their antifungal susceptibilities. J Clin Microbiol 2014; 52 (06) 2112-2125
• 108 Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002; 35 (11) 1360-1367
• 109 De Miguel D, Gómez P, González R. , et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis 2005; 53 (01) 33-37
• 110 Alanio A, Brethon B, Feuilhade de Chauvin M. , et al. Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Clin Infect Dis 2008; 46 (10) e116-e118
• 111 Akagi T, Kawamura C, Terasawa N, Yamaguchi K, Kubo K. Suspected pulmonary infection with Trichoderma longibrachiatum after allogeneic stem cell transplantation. Intern Med 2017; 56 (02) 215-219
• 112 Kviliute R, Paskevicius A, Gulbinovic J, Stulpinas R, Griskevicius L. Nonfatal Trichoderma citrinoviride pneumonia in an acute myeloid leukemia patient. Ann Hematol 2008; 87 (06) 501-502
• 113 Sautour M, Chrétien ML, Valot S. , et al. First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia. J Mycol Med 2018; 28 (04) 659-662
• 114 Festuccia M, Giaccone L, Gay F. , et al. Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report. Transpl Infect Dis 2014; 16 (04) 653-657
• 115 Markantonatou AM, Samaras K, Yannaki E, Zachrou E, Vyzantiadis TA. Aspergillus galactomannan detection: Trichoderma as a cause of positive results. Curr Microbiol 2019; 76 (01) 48-51
• 116 Ioakimidou A, Vyzantiadis TA, Sakellari I. , et al. An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit. Diagn Microbiol Infect Dis 2013; 75 (03) 313-316
• 117 Herbrecht R, Letscher-Bru V, Fohrer C. , et al. Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B. Eur J Clin Microbiol Infect Dis 2002; 21 (11) 814-817
• 118 Júnior MC, de Moraes Arantes A, Silva HM, Costa CR, Silva MdoR. Acremonium kiliense: case report and review of published studies. Mycopathologia 2013; 176 (5-6): 417-421
• 119 Boltansky H, Kwon-Chung KJ, Macher AM, Gallin JI. Acremonium strictum-related pulmonary infection in a patient with chronic granulomatous disease. J Infect Dis 1984; 149 (04) 653
• 120 Mattei D, Mordini N, Lo Nigro C. , et al. Successful treatment of Acremonium fungemia with voriconazole. Mycoses 2003; 46 (11-12): 511-514
• 121 Qazi MS, Bowalekar SS, Wanjare VS, Shankar A. An unusual case of lung abscess caused by Acremonium species treated with itraconazole. Indian J Med Microbiol 2015; 33 (02) 307-310
• 122 Yamazaki R, Mori T, Aisa Y. , et al. Systemic infection due to Acremonium after allogeneic peripheral blood stem cell transplantation. Intern Med 2006; 45 (16) 989-990
• 123 Foell JL, Fischer M, Seibold M. , et al. Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL. Pediatr Blood Cancer 2007; 49 (06) 858-861
• 124 Perdomo H, Sutton DA, García D. , et al. Spectrum of clinically relevant Acremonium species in the United States. J Clin Microbiol 2011; 49 (01) 243-256
• 125 Torres R, Gonzalez M, Sanhueza M. , et al. Outbreak of Paecilomyces variotii peritonitis in peritoneal dialysis patients after the 2010 Chilean earthquake. Perit Dial Int 2014; 34 (03) 322-325
• 126 Wright K, Popli S, Gandhi VC, Lentino JR, Reyes CV, Leehey DJ. Paecilomyces peritonitis: case report and review of the literature. Clin Nephrol 2003; 59 (04) 305-310
• 127 Williamson PR, Kwon-Chung KJ, Gallin JI. Successful treatment of Paecilomyces variotii infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis 1992; 14 (05) 1023-1026
• 128 Tarkkanen A, Raivio V, Anttila VJ. , et al. Fungal endophthalmitis caused by Paecilomyces variotii following cataract surgery: a presumed operating room air-conditioning system contamination. Acta Ophthalmol Scand 2004; 82 (02) 232-235
• 129 Gutiérrez F, Masiá M, Ramos J, Elía M, Mellado E, Cuenca-Estrella M. Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections. Eur J Clin Microbiol Infect Dis 2005; 24 (09) 607-611
• 130 Marques DP, Carvalho J, Rocha S, Domingos R. A case of pulmonary mycetoma caused by Paecilomyces variotii . Eur J Case Rep Intern Med 2019; 6 (02) 001040
• 131 Steiner B, Aquino VR, Paz AA, Silla Lda R, Zavascki A, Goldani LZ. Paecilomyces variotii as an emergent pathogenic agent of pneumonia. Case Rep Infect Dis 2013; 2013: 273848
• 132 Feldman R, Cockerham L, Buchan BW, Lu Z, Huang AM. Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review. Mycoses 2016; 59 (12) 746-750
• 133 Eren D, Eroglu E, Ulu Kilic A. , et al. Cutaneous ulcerations caused by Paecilomyces variotii in a renal transplant recipient. Transpl Infect Dis 2018; 20 (03) e12871
• 134 Salle V, Lecuyer E, Chouaki T. , et al. Paecilomyces variotii fungemia in a patient with multiple myeloma: case report and literature review. J Infect 2005; 51 (03) e93-e95
• 135 Bellanger AP, Cervoni JP, Faucher JF. , et al. Paecilomyces variotii fungemia in a patient with lymphoma needing liver transplant. Mycopathologia 2017; 182 (7-8): 761-765
• 136 Polat M, Kara SS, Tapısız A. , et al. Successful treatment of Paecilomyces variotii peritonitis in a liver transplant patient. Mycopathologia 2015; 179 (3-4): 317-320
• 137 Cohen-Abbo A, Edwards KM. Multifocal osteomyelitis caused by Paecilomyces variotii in a patient with chronic granulomatous disease. Infection 1995; 23 (01) 55-57
• 138 Castelli MV, Alastruey-Izquierdo A, Cuesta I. , et al. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother 2008; 52 (08) 2926-2928
• 139 Anaissie EJ, Stratton SL, Dignani MC. , et al. Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. Blood 2003; 101 (07) 2542-2546
• 140 Neely AN, Orloff MM. Survival of some medically important fungi on hospital fabrics and plastics. J Clin Microbiol 2001; 39 (09) 3360-3361
• 141 Itin PH, Frei R, Lautenschlager S. , et al. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol 1998; 39 (03) 401-409
• 142 Pettit TH, Olson RJ, Foos RY, Martin WJ. Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch Ophthalmol 1980; 98 (06) 1025-1039
• 143 Orth B, Frei R, Itin PH. , et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 1996; 125 (10) 799-806
• 144 Khan Z, Ahmad S, Al-Ghimlas F. , et al. Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate. J Clin Microbiol 2012; 50 (05) 1800-1804
• 145 Ono N, Sato K, Yokomise H, Tamura K. Lung abscess caused by Paecilomyces lilacinus . Respiration 1999; 66 (01) 85-87
• 146 Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2008; 10 (02) 117-122
• 147 Tan TQ, Ogden AK, Tillman J, Demmler GJ, Rinaldi MG. Paecilomyces lilacinus catheter-related fungemia in an immunocompromised pediatric patient. J Clin Microbiol 1992; 30 (09) 2479-2483
• 148 Chan-Tack KM, Thio CL, Miller NS, Karp CL, Ho C, Merz WG. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol 1999; 37 (01) 57-60
• 149 Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39 (03) 954-958
• 150 Rodríguez MM, Pastor FJ, Serena C, Guarro J. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus . J Antimicrob Chemother 2009; 63 (02) 361-364
• 151 Rimawi RH, Carter Y, Ware T, Christie J, Siraj D. Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature. Mycopathologia 2013; 175 (3-4): 345-349
• 152 Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2006; 12 (10) 948-960
• 153 Avilés-Robles M, Gómez-Ponce C, Reséndiz-Sánchez J, Rodríguez-Tovar AV, Ceballos-Bocanegra A, Martínez-Rivera Á. Disseminated penicilliosis due to Penicillium chrysogenum in a pediatric patient with Henoch-Schönlein syndrome. Int J Infect Dis 2016; 51 (51) 78-80
• 154 Lyratzopoulos G, Ellis M, Nerringer R, Denning DW. Invasive infection due to penicillium species other than P. marneffei . J Infect 2002; 45 (03) 184-195
• 155 Fergusson RJ, Milne LJR, Crompton GK. Penicillium allergic alveolitis: faulty installation of central heating. Thorax 1984; 39 (04) 294-298
• 156 Sahn SA, Lakshminarayan S. Allergic bronchopulmonary penicilliosis. Chest 1973; 63 (02) 286-288
• 157 Park HS, Jung KS, Kim SO, Kim SJ. Hypersensitivity pneumonitis induced by Penicillium expansum in a home environment. Clin Exp Allergy 1994; 24 (04) 383-385
• 158 Barcus AL, Burdette SD, Herchline TE. Intestinal invasion and disseminated disease associated with Penicillium chrysogenum . Ann Clin Microbiol Antimicrob 2005; 4: 21
• 159 Mok T, Koehler AP, Yu MY, Ellis DH, Johnson PJ, Wickham NW. Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia. J Clin Microbiol 1997; 35 (10) 2654-2656
• 160 López-Martínez R, Neumann L, González-Mendoza A. Case report: cutaneous penicilliosis due to Penicillium chrysogenum . Mycoses 1999; 42 (04) 347-349
• 161 Reboux G, Rocchi S, Vacheyrou M, Millon L. Identifying indoor air Penicillium species: a challenge for allergic patients. J Med Microbiol 2019; 68 (05) 812-821
• 162 Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003; 41 (08) 3623-3626
• 163 McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ. Novel agents and drug targets to meet the challenges of resistant fungi. J Infect Dis 2017; 216 (Suppl. 03) S474-S483
• 164 Oliver JD, Sibley GEM, Beckmann N. , et al. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci U S A 2016; 113 (45) 12809-12814
• 165 Wiederhold NP, Law D, Birch M. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans . J Antimicrob Chemother 2017; 72 (07) 1977-1980
• 166 Castanheira M, Duncanson FP, Diekema DJ, Guarro J, Jones RN, Pfaller MA. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrob Agents Chemother 2012; 56 (01) 352-357
• 167 Pfaller MA, Huband MD, Flamm RK, Bien PA, Castanheira M. In Vitro activity of APX001A (Manogepix) and comparator agents against 1,706 fungal isolates collected during an International Surveillance Program in 2017. Antimicrob Agents Chemother 2019; 63 (08) 1-11
• 168 Hata K, Horii T, Miyazaki M. , et al. Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis. Antimicrob Agents Chemother 2011; 55 (10) 4543-4551
• 169 Miyazaki M, Horii T, Hata K. , et al. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds. Antimicrob Agents Chemother 2011; 55 (10) 4652-4658